Medindia LOGIN REGISTER
Medindia
Advertisement

Treatment for Coronavirus In Early Lab Tests Shows Promise

by Bidita Debnath on April 24, 2013 at 7:51 PM
 Treatment for Coronavirus In Early Lab Tests Shows Promise

Scientists studying an emerging coronavirus have found that a combination of two licensed antiviral drugs, ribavirin and interferon-alpha 2b, can stop the virus from replicating in laboratory-grown cells.

The study took place in National Institutes of Health (NIH). These results suggest that the drug combination could be used to treat patients infected with the new coronavirus, but more research is needed to confirm this preliminary finding. The study appears in the April 18, 2013, issue of Scientific Reports.

Advertisement

The new coronavirus, called nCoV, was first identified in Saudi Arabia in September 2012. As of April 16, 2013, the World Health Organization has reported 17 cases with 11 deaths, primarily in the Middle East. Although the case count is small, the new coronavirus has transmitted from human-to-human in situations where people—mainly family members—have had close contact with those infected.

Because of the high fatality rate, scientists at NIH's National Institute of Allergy and Infectious Diseases (NIAID) saw an urgent need to identify therapeutic options. In laboratory tests using cells from two species of monkey, the researchers found that either ribavirin or interferon-alpha 2b, drugs currently approved for hepatitis C therapy, inhibited nCoV from replicating when used individually. However, the required drug concentrations exceeded what is recommended for people. By combining the two antivirals, the scientists established an effective treatment dose at a drug level that is achievable in people. The NIAID researchers plan to confirm these results in a recently developed monkey model of nCoV infection.

Source: Eurekalert
Font : A-A+

Advertisement

Advertisement
Advertisement

Recommended Readings

Latest Coronavirus News

Chest Pain, Heart Rhythm Problems in Long COVID Cases
Study highlights cardiac complications persisting in Long COVID patients: chest pain, abnormal heart rhythms.
High Steroid Dose for COVID-19: Less Effective in India Than Europe?
A larger dose of dexamethasone (12 mg) appeared to be less effective than the standard dose (6 mg) for COVID-19 patients in India.
Surge in Premature Births Linked to COVID, Vaccination Proves Protective
New study explores how COVID-19 vaccination might have spared a generation of American children from the enduring health challenges and expenses linked to premature birth.
Lower COVID-19 Booster Dose for Adults Optimizes Immunity
Recent study reveals the immune response in adults after reducing the standard COVID-19 booster vaccine.
COVID-19: India Reports 31 New Infections
India's COVID case count reached 450.01 million (4.50 crore), with the administration of 2.21 billion (220.67 crore) COVID vaccine doses.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
×

Treatment for Coronavirus In Early Lab Tests Shows Promise Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests